The mixture of HVJ-E and CXCL2 plasmid DNA succeeded in enhancing CXCL2 expression in the tumor mass and displayed anti-tumor activity by enhancing CTL activity against cancer cells, which resulted from the accumulation of N1-type TANs. This evidence concerns the gene CXCL2 and cancer.